About the Centre

About Addiction

About Mental Health

Community Health & Education

Research

         
 
CAMH

Information Bulletin

GHB (Gamma-hydroxy-butyrate)

 
CAMH Foundation
Education
CAMH Publications
Volunteers
Career Opportunities
 


The purpose of this information sheet is to provide the public and health care professionals with accurate information about GHB and its use.


What is GHB?

GHB was first synthesized in 1960 and was developed for use as a hypnotic agent. It was discarded because of its inability to reliably induce a sleep deep enough for surgery. Its use was also associated with several serious side effects, including seizures.

It is commonly referred to on the streets as Liquid X, Liquid E, GBH or Grievous Bodily Harm and Easy Lay.

GHB is a clear, odourless and tasteless liquid. Because of these characteristics and the fact that its sedative and hypnotic effects are increased by alcohol, GHB has been used in the context of "date rape" where the drug is poured into the drink of an unsuspecting person.

GHB is produced naturally in the body and is structurally similar to gamma amino butyric acid (GABA). Its function in the body is unknown. It was sold in health food stores in the U.S. until 1989, when the U.S. Food and Drug Administration classified it as a controlled substance. Recently though, there appears to have been a resurgence in the use of GHB as clandestine laboratories have sprung up to manufacture the drug using recipes widely available on the internet.

GHB is listed as a controlled substance under Section 3 of the Controlled Drugs and Substances Act in Canada, and is prohibited for sale in this country. The drug is a Schedule I Controlled Substance in the U.S. making it illegal to possess with the intent to manufacture, distribute or dispense.

to top

What are the effects?

Administration of GHB causes central nervous system (CNS) depressant effects (e.g. sedation) as well as euphoric effects. It has been investigated clinically for the treatment of alcohol withdrawal and for sleep disorders.

It is used illicitly for its sedative and euphoric effects. It is also claimed to promote muscle development. Adverse effects associated with GHB include dizziness, nausea and vomiting, amnesia, seizures, hallucination, difficulty with breathing, unconsciousness and coma. It has increasingly surfaced as a drug at "raves", nightclubs and bars.

False claims have been made about GHB. It has been promoted illegally as a health food product, a hypnotic, an aphrodisiac and, for body builders, as a steroid alternative. Its sedating effects are claimed to buffer aggressiveness, a common side effect in anabolic steroid users. Its effects on sleep are due to its ability to facilitate slow wave sleep, while decreasing sleep stages 1 and 2. Growth hormone is released during slow wave sleep; by promoting slow wave sleep, it has been purported that increased growth hormone release occurs, leading to muscle building effects. The efficacy of GHB in promoting muscle development has not been demonstrated.

Most of the GHB on the street is in liquid form, prepared in home laboratories. The strength of this homemade GHB can vary considerably so users don't know how much they are getting. What is thought to be a small dose, could actually turn out to be a toxic dose. Since the actual amounts of GHB consumed are unknown (due to the variability in product concentration) the risk of overdose is great. This risk increases when the user combines GHB with other psychoactive drugs such as benzodiazepines and / or alcohol. Cases of intoxication require emergency hospital treatment. It is often difficult to distinguish alcohol intoxication from GHB intoxication. GHB intoxication can occur rapidly and if one is aware that a friend has taken the drug, one should monitor the friend for increased drowsiness, nausea, vomiting, headache, impaired breathing, seizures or loss of consciousness.

Following oral administration, GHB is quickly absorbed; peak concentrations are reached in 20-60 minutes and the effects generally last up to 4 hours depending on the amount taken. Most of the acute symptoms resolve after about seven hours, but dizziness has been known to persist for up to two weeks.

Within 15-30 minutes following ingestion, the following effects can occur depending on the amount ingested: drowsiness, nausea, vomiting, amnnesia and vertigo. This may be followed by loss of consciousness, coma, depressed respiration, tonic-clonic seizures and / or hypotension. Respiratory arrest has also been reported.

Recent information from participants at raves and emergency visits to hospitals includes reports that GHB overdoses are becoming more prevalent.

There have been some reports of GHB-related deaths in the United States confirmed by the Drug Enforcement Agency.

For more information on mental health or addiction issues, please call the Centre for Addiction and Mental Health at 1-800-463-6273, or in Toronto at (416) 595-6111.

to top

 
On this page
For further information
Related Pages
Ecstasy -- PDF Version
GHB
GHB -- PDF Version
 
How to Reach Us
 

 

 

For general information on addiction and mental health:

Call the R. Samuel McLaughlin Addiction and Mental Health Information Centre

Toll free in Ontario Tel:1-800-463-6273
or local (416) 595-6111

www.camh.net/mclaughlin

DISCLAIMER: The Centre is not able to provide diagnostic, treatment or referral services through the Internet. Individuals should contact their family doctors, or their local mental health or addiction agency for further information.


to top

© Copyright
Centre for Addiction and Mental Health

33 Russell Street, Toronto
Ontario, Canada M5S 2S1.
Telephone: (416) 535-8501

The Centre is fully affiliated with
the
University of Toronto.

A Pan American Health Organization
and World Health Organization
Collaborating Centre

For inquiries regarding the content of this page, contact

Please direct technical questions or comments about this site to

If you are a spammer or spam-harvesting robot, please send mail to imaspammer-on@lists.camh.net.

     


 

This page was last modified on February 5, 2003 9:31 AM .